Carbapenem Resistant Organisms, Isolate Testing

Laboratory Fee Schedule
Procedure Number: N/A 

Synonym(s):Carbapenem Resistant Enterobacterales, Carbapenem Resistant Pseudomonas aeruginosa, Carbapenem Resistant Acinetobacter baumanii, CRE, CRPA, CRAB, CRO, ARLN, Carbapenem, Antimicrobial resistance, Antimicrobial Susceptibility Test, PCR, Antimicrobial, MALDI-TOF, mCIM, Broth Micro Dilution
Requisition FormG-2E
Test DescriptionDefinitive identification of CRO isolates by MALDI-TOF, antimicrobial susceptibility determined by broth micro dilution, and carbapenemase production determination by real-time PCR.
Pre-Approval NeededN/A 
Supplemental Information Required
  • Antimicrobial susceptibility report from submitter
  • Copies of any previous Lab tests (carbapenemase production or PCR), if available. 
Supplemental Form(s)N/A
Performed on Specimens from (sources)Human
Sample/Specimen Type for Testing
  • Pure-cultured CRO isolate from any type of clinical specimen grown on a non-inhibitory, non-selective agar plate or/slant or broth.
  • Pure-cultured CRE isolates resistant to any imipenem, meropenem or ertapenem.
  • Pure-cultured CRPA isolates resistant to at least one imipenem, or meropenem AND non-susceptible (intermediate or resistant) to cefepime or ceftazidime.
  •  CRAB isolates resistant to imipenem, or meropenem.
Minimum Volume/Size Required
  • At least one viable pure isolate per plate or slant.
  • Single tube of pure culture isolate.
Storage/Preservation Prior to Shipping
  • Store and ship isolates at ambient temperatures.
  • Ensure that growth media used does not expire before specimen collection date. 
Transport Medium
  • Isolates should be submitted on a non-inhibitory, non-selective agar plate or/slant or broth.
Specimen Labeling
  • At least two patient identifiers required on specimen (e.g., patient full name, date of birth, medical record number).
  • Three patient identifiers are preferred.
  • Identifiers on specimen must exactly match identifiers in submission form (e.g. abbreviated name on label and full name on form is not acceptable).
  • Additional DSHS Laboratory specimen labeling guidelines available online here.
Shipping and Specimen Handling Requirements
  • Ship according to Dangerous Goods Regulations, IATA, and/or CFR 49
  • Category B Biological Substance, UN3373 shipping requirements apply
  • Submitters are responsible for packaging and shipping specimens according to regulatory requirements.
  • Additional DSHS Laboratory submission guidelines available online here.
Method
  • Identification of CRE, CRPA, and CRAB by MALDI-TOF.
  • Antimicrobial susceptibility testing by broth micro dilution.
  • Carbapenemase production in CRE and CRPA determined by modified Carbapenem Inactivation Method (mCIM). Carbapenemase producing CRE, CRPA and CRAB identified by real-time PCR.
Turn-around Time7 working days
Interferences/Limitations
  • Organisms must be viable for culture studies.
  • The results from this test should be used only for epidemiological purposes and not for patient treatment.
Common Causes for Rejection
  • Mixed culture submitted.
  • Insufficient specimen growth.
  • Antimicrobial susceptibility result not provided by submitter.
  • Missing identifiers on specimen and/or submission form.
  • Isolate submitted not a target organism.
  • Media expired at time of isolate culture.
  • Discrepancies between specimen label and submission form
  • Incomplete, missing, or illegible submission form.
  • Specimen collection guidance available from AR Laboratory, email TexasARLN@dshs.texas.gov or refer to online guidance.
Additional InformationN/A